Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Bruce Vielle joins the company following a seven-year tenure as CEO of Synerlab Group/Meribel Pharma Solutions.
July 23, 2026
By: Charlie Sternberg
Associate Editor
Famar, a European contract development and manufacturing organization (CDMO), has appointed Bruce Vielle as Chief Executive Officer (CEO), effective August 3, 2026. He succeeds Dr. Riku Rautsola, who has led the company as interim CEO since autumn 2025 and who will work closely with Vielle to ensure a smooth transition.
“On behalf of the Board and MidEuropa, I am very pleased to welcome Bruce to Famar,” said Peter Prock, Chairman of Famar. “He is a proven CDMO leader with a strong track record in operational execution, sterile manufacturing and value creation, the experience Famar needs as we invest in new capabilities and become an even stronger and agile partner for our customers.”
Vielle has spent his career leading complex, multi-site manufacturing organizations. For the past seven years, he has been CEO of Synerlab Group and its successor, Meribel Pharma Solutions, most recently leading 2,000 employees across 13 manufacturing sites in France, Spain and Sweden.
Before that, he was Chief Operating Officer of Vétoquinol, a top-10 global animal health company, and he began his pharmaceutical career in site leadership roles at Unither. Throughout, he has served demanding, blue-chip pharmaceutical, biotech and medtech customers across a broad range of complex dosage forms, with a consistent focus on disciplined execution, quality and reliability of supply.
An engineer by training, Vielle holds an Executive MBA from HEC Paris and is an expert in Lean manufacturing and Six Sigma.
“I am delighted and energized to be joining Famar. This is a company with a strong European footprint, trusted customer relationships and talented people, and I see significant opportunity ahead of us,” Vielle remarked. “Our customers are growing, and Famar’s role is to grow with them by investing in the capabilities, capacity and service they need, from development through to commercial supply. I look forward to working with the leadership team and colleagues at every site to deliver for our customers.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !